Literature DB >> 2116217

Viral hepatitis comparative epidemiology.

R Wright1.   

Abstract

The epidemiology of HAV, HBV, HCV, HDV and HEV is compared. Spread of HAV and HEV is by the faecal/oral route whereas HBV, HCV and HDV are spread by blood or blood products. HEV is more likely to produce large epidemics than HAV but sporadic cases also occur. HBV, HCV and HDV all occur after blood transfusion, in haemophiliacs and intravenous drug abusers but they differ in their geographical distribution and in the frequency of perinatal transmission which is only common with HBV. Superinfection and interaction between these viruses is discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2116217     DOI: 10.1093/oxfordjournals.bmb.a072415

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  5 in total

Review 1.  Viruses and human cancers: a long road of discovery of molecular paradigms.

Authors:  Martyn K White; Joseph S Pagano; Kamel Khalili
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan.

Authors:  C J Chang; C H Lin; C T Lee; S J Chang; Y C Ko; H W Liu
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

3.  Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus.

Authors:  Y E Khudyakov; E N Lopareva; D L Jue; T K Crews; S P Thyagarajan; H A Fields
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

4.  AUSTRALIA ANTIGEN (HBsAG) IN INSTITUTIONALISED SCHIZOPHRENICS.

Authors:  S Chaudhury; S Chandra; G S Chopra; M Augustine
Journal:  Indian J Psychiatry       Date:  1993-01       Impact factor: 1.759

5.  Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence study.

Authors:  S S Al-Dhahry; P N Aghanashinikar; H A Al-Marhuby; M R Buhl; A S Daar; M K Al-Hasani
Journal:  Ann Saudi Med       Date:  1994-07       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.